Plasma ACE-2 and risk of death or cardiometabolic diseases

This is one of the largest studies to highlight the importance of elevated levels of plasma ACE2 and the risk of death. The data demonstrated here shows how relevant plasma ACE2 is in the context of cardiometabolic disease.

Our hypothesis on autoimmunity to ACE2 in COVID-19 had this as central. It explains why certain groups will be at higher risk of sev…